Lee Roy McCracken
Director/Board Member chez HTG MOLECULAR DIAGNOSTICS, INC.
Fortune : - $ au 31/03/2024
Profil
Lee Roy McCracken currently works at Drawbridge Health, Inc., as Chief Executive Officer & Director from 2017, Global Medical & Research Technologies, Inc., as Chairman from 2015, and HTG Molecular Diagnostics, Inc., as Independent Director from 2015.
Mr. McCracken also formerly worked at Pathwork Diagnostics, Inc., as President & Chief Executive Officer from 2012 to 2013, Gensignia Life Sciences, Inc., as Chief Executive Officer from 2014 to 2016, Nephrosant, Inc., as Chief Executive Officer, Allergan, Inc., as Director-Business Development-Americas Region, NextGen Group Plc, as Executive Director in 2012, Pacific Pharma LP, as Managing Director, Corautus Genetics, Inc., as President & Chief Business Officer from 2000 to 2002, CombiChem, Inc., as Senior Vice President-Corporate Development, Diversa Corp., as Senior VP-Pharmaceutical Business Development in 2004, Union Venture Capital Corp., as Principal, and Prometheus Laboratories, Inc., as Vice President-Development from 2010 to 2011.
Mr. McCracken received his undergraduate degree from Santa Clara University, graduate degree from the University of Dayton, and Masters Business Admin degree from Anderson School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/03/2023 | 27 ( 0,00% ) | 0 $ | 31/03/2024 |
Postes actifs de Lee Roy McCracken
| Sociétés | Poste | Début |
|---|---|---|
| HTG MOLECULAR DIAGNOSTICS, INC. | Director/Board Member | 27/10/2015 |
Drawbridge Health, Inc.
 Drawbridge Health, Inc. Medical SpecialtiesHealth Technology Drawbridge Health, Inc. manufactures medical equipment. The firm specializes in medical device, blood collection, health technology, blood sampling, and medical technology. The company was founded by Alicia Jackson and Harry A. Glorikian and is headquartered in San Diego, CA. | Chief Executive Officer | 01/06/2017 |
| Global Medical & Research Technologies, Inc. | Chairman | 01/10/2015 |
Anciens postes connus de Lee Roy McCracken
| Sociétés | Poste | Fin |
|---|---|---|
Gensignia Life Sciences, Inc.
 Gensignia Life Sciences, Inc. BiotechnologyHealth Technology Gensignia Life Sciences, Inc. is a molecular diagnostics company that develops new molecular diagnosis techniques. The private company is based in San Diego, CA. The company was founded by Gabriele Marco Antonio Cerrone. | Chief Executive Officer | 01/05/2016 |
Pathwork Diagnostics, Inc.
 Pathwork Diagnostics, Inc. Medical SpecialtiesHealth Technology Pathwork Diagnostics Inc. develops and delivers molecular diagnostics for oncology. The company was founded by Glenda Anderson, Richard Zare, and George M. Whitesides in 2003 and is headquartered in Redwood City, CA. | Chief Executive Officer | 01/03/2013 |
NextGen Group Plc
 NextGen Group Plc Miscellaneous Commercial ServicesCommercial Services NextGen Group Plc provides protein biomarker testing services for pharmaceutical and biotech companies. Its services include biomarker discover, assay development and testing laboratory. The company's biomarker assay used to test pre-clinical and clinical samples for drug efficacy and safety, and for the development of personalized treatment for patients. Its biomarker services include protein identification, characterization, quantitation and proteome mapping. The company was founded on September 7, 2005 and is headquartered in London, the United Kingdom. | Director/Board Member | 10/08/2012 |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/12/2011 |
Diversa Corp.
 Diversa Corp. Miscellaneous Commercial ServicesCommercial Services Diversa searches high and low for DNA. In its quest to develop new enzymes and other active biological compounds, the biotechnology company collects and catalogs the DNA of organisms in diverse environments (from manure piles to tropical islands). A variety of manufacturers license these compounds from the firm to develop or improve their products, which include detergents, oils, animal feeds, and pharmaceuticals. Diversa's products include enzymes for the oil and gas industry | Corporate Officer/Principal | 01/03/2004 |
Formation de Lee Roy McCracken
| Santa Clara University | Undergraduate Degree |
| University of Dayton | Graduate Degree |
| Anderson School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HTG MOLECULAR DIAGNOSTICS, INC. | Commercial Services |
| Entreprise privées | 13 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Corautus Genetics, Inc.
 Corautus Genetics, Inc. Pharmaceuticals: MajorHealth Technology Corautus Genetics Inc. is a biopharmaceutical company, which manufactures gene therapy products for the treatment of cardiac and vascular disease & peripheral vascular disease. It is located in Atlanta, GA. | Health Technology |
CombiChem, Inc.
 CombiChem, Inc. Miscellaneous Commercial ServicesCommercial Services CombiChem, Inc. used to provide computational drug recovery services to accelerate the discovery process for new drugs and chemical compounds. The company was founded in 1994 and headquartered in San Diego, CA | Commercial Services |
Diversa Corp.
Diversa Corp. Miscellaneous Commercial ServicesCommercial Services Diversa searches high and low for DNA. In its quest to develop new enzymes and other active biological compounds, the biotechnology company collects and catalogs the DNA of organisms in diverse environments (from manure piles to tropical islands). A variety of manufacturers license these compounds from the firm to develop or improve their products, which include detergents, oils, animal feeds, and pharmaceuticals. Diversa's products include enzymes for the oil and gas industry | Commercial Services |
NextGen Group Plc
NextGen Group Plc Miscellaneous Commercial ServicesCommercial Services NextGen Group Plc provides protein biomarker testing services for pharmaceutical and biotech companies. Its services include biomarker discover, assay development and testing laboratory. The company's biomarker assay used to test pre-clinical and clinical samples for drug efficacy and safety, and for the development of personalized treatment for patients. Its biomarker services include protein identification, characterization, quantitation and proteome mapping. The company was founded on September 7, 2005 and is headquartered in London, the United Kingdom. | Commercial Services |
| Union Venture Capital Corp. | |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Health Technology |
Pathwork Diagnostics, Inc.
Pathwork Diagnostics, Inc. Medical SpecialtiesHealth Technology Pathwork Diagnostics Inc. develops and delivers molecular diagnostics for oncology. The company was founded by Glenda Anderson, Richard Zare, and George M. Whitesides in 2003 and is headquartered in Redwood City, CA. | Health Technology |
| Pacific Pharma LP | |
Gensignia Life Sciences, Inc.
Gensignia Life Sciences, Inc. BiotechnologyHealth Technology Gensignia Life Sciences, Inc. is a molecular diagnostics company that develops new molecular diagnosis techniques. The private company is based in San Diego, CA. The company was founded by Gabriele Marco Antonio Cerrone. | Health Technology |
Drawbridge Health, Inc.
Drawbridge Health, Inc. Medical SpecialtiesHealth Technology Drawbridge Health, Inc. manufactures medical equipment. The firm specializes in medical device, blood collection, health technology, blood sampling, and medical technology. The company was founded by Alicia Jackson and Harry A. Glorikian and is headquartered in San Diego, CA. | Health Technology |
| Global Medical & Research Technologies, Inc. | |
Nephrosant, Inc.
 Nephrosant, Inc. BiotechnologyHealth Technology Nephrosant, Inc. is a company dedicated to improving kidney health through noninvasive diagnostic tests. The company is based in Brisbane, CA. The company's flagship diagnostic test is QSant, a noninvasive urine-based test that supports early detection of kidney rejection risk. Nephrosant plans to develop centralized lab tests and point of care tests for kidney diseases and allograft monitoring for other organs. Founded in 2017 by Dr. Minnie Sarwal and UCSF physicians, the company has a team of world-class scientists, engineers, and clinicians who have licensed the founding team's clinical research to develop diagnostic tests for chronic kidney disease. Dr. Sarwal has been the CEO since 2017. | Health Technology |
